BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 16585173)

  • 1. Distinct tumor stage-specific inhibitory effects of 2-methoxyestradiol in a breast cancer mouse model associated with Id-1 expression.
    Huh JI; Calvo A; Charles R; Green JE
    Cancer Res; 2006 Apr; 66(7):3495-503. PubMed ID: 16585173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 2-difluoromethylornithine and dehydroepiandrosterone inhibit mammary tumor progression but not mammary or prostate tumor initiation in C3(1)/SV40 T/t-antigen transgenic mice.
    Green JE; Shibata MA; Shibata E; Moon RC; Anver MR; Kelloff G; Lubet R
    Cancer Res; 2001 Oct; 61(20):7449-55. PubMed ID: 11606379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 2-Methoxyestradiol suppresses osteolytic breast cancer tumor progression in vivo.
    Cicek M; Iwaniec UT; Goblirsch MJ; Vrabel A; Ruan M; Clohisy DR; Turner RR; Oursler MJ
    Cancer Res; 2007 Nov; 67(21):10106-11. PubMed ID: 17974950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapamycin inhibits growth of premalignant and malignant mammary lesions in a mouse model of ductal carcinoma in situ.
    Namba R; Young LJ; Abbey CK; Kim L; Damonte P; Borowsky AD; Qi J; Tepper CG; MacLeod CL; Cardiff RD; Gregg JP
    Clin Cancer Res; 2006 Apr; 12(8):2613-21. PubMed ID: 16638874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 2-methoxyestradiol induces mammary gland differentiation through amphiregulin-epithelial growth factor receptor-mediated signaling: molecular distinctions from the mammary gland of pregnant mice.
    Huh JI; Qiu TH; Chandramouli GV; Charles R; Wiench M; Hager GL; Catena R; Calvo A; LaVallee TM; Desprez PY; Green JE
    Endocrinology; 2007 Mar; 148(3):1266-77. PubMed ID: 17158205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estrogen promotes mammary tumor development in C3(1)/SV40 large T-antigen transgenic mice: paradoxical loss of estrogen receptoralpha expression during tumor progression.
    Yoshidome K; Shibata MA; Couldrey C; Korach KS; Green JE
    Cancer Res; 2000 Dec; 60(24):6901-10. PubMed ID: 11156389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physiologic levels of 2-methoxyestradiol interfere with nongenomic signaling of 17beta-estradiol in human breast cancer cells.
    Vijayanathan V; Venkiteswaran S; Nair SK; Verma A; Thomas TJ; Zhu BT; Thomas T
    Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2038-48. PubMed ID: 16609013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hormonal and dietary modulation of mammary carcinogenesis in mouse mammary tumor virus-c-erbB-2 transgenic mice.
    Yang X; Edgerton SM; Kosanke SD; Mason TL; Alvarez KM; Liu N; Chatterton RT; Liu B; Wang Q; Kim A; Murthy S; Thor AD
    Cancer Res; 2003 May; 63(10):2425-33. PubMed ID: 12750262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of mammary tumorigenesis in transgenic mice by the RXR-selective retinoid, LGD1069.
    Wu K; Kim HT; Rodriquez JL; Hilsenbeck SG; Mohsin SK; Xu XC; Lamph WW; Kuhn JG; Green JE; Brown PH
    Cancer Epidemiol Biomarkers Prev; 2002 May; 11(5):467-74. PubMed ID: 12010861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence that 2-methoxyestradiol suppresses proliferation and accelerates apoptosis in normal rat growth plate chondrocytes.
    Sibonga JD; Sommer U; Turner RT
    J Cancer Res Clin Oncol; 2002 Sep; 128(9):477-83. PubMed ID: 12242511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Broad antitumor activity in breast cancer xenografts by motesanib, a highly selective, oral inhibitor of vascular endothelial growth factor, platelet-derived growth factor, and Kit receptors.
    Coxon A; Bush T; Saffran D; Kaufman S; Belmontes B; Rex K; Hughes P; Caenepeel S; Rottman JB; Tasker A; Patel V; Kendall R; Radinsky R; Polverino A
    Clin Cancer Res; 2009 Jan; 15(1):110-8. PubMed ID: 19118038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 2-methoxyestradiol induces morpho-functional changes and impairs the microtubular system in mouse neuroblastoma and rat glioma cells.
    Manca P; Chisu V
    Arch Ital Biol; 2010 Mar; 148(1):11-21. PubMed ID: 20426250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crosstalk between extrinsic and intrinsic cell death pathways in pancreatic cancer: synergistic action of estrogen metabolite and ligands of death receptor family.
    Basu A; Castle VP; Bouziane M; Bhalla K; Haldar S
    Cancer Res; 2006 Apr; 66(8):4309-18. PubMed ID: 16618756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Haploid loss of Ki-ras delays mammary tumor progression in C3 (1)/SV40 Tag transgenic mice.
    Liu ML; Shibata MA; Von Lintig FC; Wang W; Cassenaer S; Boss GR; Green JE
    Oncogene; 2001 Apr; 20(16):2044-9. PubMed ID: 11360188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural and synthetic progestins accelerate 7,12-dimethylbenz[a]anthracene-initiated mammary tumors and increase angiogenesis in Sprague-Dawley rats.
    Benakanakere I; Besch-Williford C; Schnell J; Brandt S; Ellersieck MR; Molinolo A; Hyder SM
    Clin Cancer Res; 2006 Jul; 12(13):4062-71. PubMed ID: 16818706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Inhibitive effects of mifepristone on growth of breast cancer: experiment with animal model].
    Tian XS; Zhou WH; Wu GJ; Sun JZ; Cong MH
    Zhonghua Yi Xue Za Zhi; 2008 Feb; 88(8):559-63. PubMed ID: 18649774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of cloned tumstatin-related and angiogenesis-inhibitory peptides on proliferation and apoptosis of endothelial cells.
    Zhang GM; Zhang YM; Fu SB; Liu XH; Fu X; Yu Y; Zhang ZY
    Chin Med J (Engl); 2008 Nov; 121(22):2324-30. PubMed ID: 19080341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemotherapy of breast cancer-additive anticancerogenic effects by 2-methoxyestradiol?
    Mueck AO; Seeger H; Huober J
    Life Sci; 2004 Jul; 75(10):1205-10. PubMed ID: 15219808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro effects of 2-methoxyestradiol on MCF-12A and MCF-7 cell growth, morphology and mitotic spindle formation.
    Van Zijl C; Lottering ML; Steffens F; Joubert A
    Cell Biochem Funct; 2008; 26(5):632-42. PubMed ID: 18508385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 2-Methoxyestradiol and multidrug resistance: can 2-methoxyestradiol chemosensitize resistant breast cancer cells?
    Azab SS; Salama SA; Abdel-Naim AB; Khalifa AE; El-Demerdash E; Al-Hendy A
    Breast Cancer Res Treat; 2009 Jan; 113(1):9-19. PubMed ID: 18228136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.